The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
von Hahn, Thomas
Colpitts, Che C
Schang, Luis M
Manns, Michael P
MetadataShow full item record
AbstractHepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. Current antiviral therapy fails to clear infection in a substantial proportion of cases. Drug development is focused on nonstructural proteins required for RNA replication. Individuals undergoing orthotopic liver transplantation face rapid, universal reinfection of the graft. Therefore, antiviral strategies targeting the early stages of infection are urgently needed for the prevention of HCV infection. In this study, we identified the polyphenol, epigallocatechin-3-gallate (EGCG), as an inhibitor of HCV entry. Green tea catechins, such as EGCG and its derivatives, epigallocatechin (EGC), epicatechin gallate (ECG), and epicatechin (EC), have been previously found to exert antiviral and antioncogenic properties. EGCG had no effect on HCV RNA replication, assembly, or release of progeny virions. However, it potently inhibited Cell-culture-derived HCV (HCVcc) entry into hepatoma cell lines as well as primary human hepatocytes. The effect was independent of the HCV genotype, and both infection of cells by extracellular virions and cell-to-cell spread were blocked. Pretreatment of cells with EGCG before HCV inoculation did not reduce HCV infection, whereas the application of EGCG during inoculation strongly inhibited HCV infectivity. Moreover, treatment with EGCG directly during inoculation strongly inhibited HCV infectivity. Expression levels of all known HCV (co-)receptors were unaltered by EGCG. Finally, we showed that EGCG inhibits viral attachment to the cell, thus disrupting the initial step of HCV cell entry.
CitationThe green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. 2011, 54 (6):1947-55 Hepatology
JournalHepatology (Baltimore, Md.)
The following license files are associated with this item:
- (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
- Authors: Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouillé Y, Séron K
- Issue date: 2012 Mar
- (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
- Authors: Huang HC, Tao MH, Hung TM, Chen JC, Lin ZJ, Huang C
- Issue date: 2014 Nov
- (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
- Authors: Chen C, Qiu H, Gong J, Liu Q, Xiao H, Chen XW, Sun BL, Yang RG
- Issue date: 2012 Jul
- Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
- Authors: Anggakusuma, Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ, Bankwitz D, Steinmann J, Ott M, Meuleman P, Rice CM, Ploss A, Pietschmann T, Steinmann E
- Issue date: 2014 Jul
- Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
- Authors: Calland N, Sahuc ME, Belouzard S, Pène V, Bonnafous P, Mesalam AA, Deloison G, Descamps V, Sahpaz S, Wychowski C, Lambert O, Brodin P, Duverlie G, Meuleman P, Rosenberg AR, Dubuisson J, Rouillé Y, Séron K
- Issue date: 2015 Oct